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Abstract
Background: Extracorporeal membrane oxygenation (ECMO) is a technique widely
used worldwide to improve gas exchange. Changes in ECMO settings affect both
oxygen and carbon dioxide. The impact on oxygenation can be followed closely by
continuous pulse oximeter. Conversely, carbon dioxide equilibrates much slower and
is not usually monitored directly.
Methods: We investigated the time to stabilization of arterial carbon dioxide partial
pressure (PaCO2) following step changes in ECMO settings in 5 apnoeic porcine
models under veno-venous ECMO support with polymethylpentene membranes. We
collected sequential arterial blood gases at a pre-specified interval of 50 min using a
sequence of standardized blood and sweep gas flow combinations.
Results: Following the changes in ECMO parameters, the kinetics of carbon dioxide
was dependent on sweep gas and ECMO blood flow. With a blood flow of 1500 mL/
min, PaCO2 takes longer than 50 min to equilibrate following the changes in sweep
gas flow. Furthermore, the sweep gas flow from 3.0 to 10.0 L/min did not
significantly affect PaCO2. However, with a blood flow of 3500 mL/min, 50 min was
enough for PaCO2 to reach the equilibrium and every increment of sweep gas flow
(up to 10.0 L/min) resulted in additional reductions of PaCO2.
Conclusions: Fifty minutes was enough to reach the equilibrium of PaCO2 after
ECMO initiation or after changes in blood and sweep gas flow with an ECMO blood
flow of 3500 ml/min. Longer periods may be necessary with lower ECMO blood
flows.
Keywords: Acute respiratory distress syndrome, Mechanical ventilation, Swine and
extracorporeal membrane oxygenation
Background
Extracorporeal membrane oxygenation (ECMO) has been successfully used to support
severely hypoxemic patients [1–7]. Despite the worldwide increase in ECMO support
use, there are few studies exploring the physiology of polymethylpentene membranes
in the veno-venous configuration [8, 9].
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After initiation of extracorporeal support, blood flow and sweep gas flow are adjusted
to achieve target values of arterial oxygen (PaO2), pH, and carbon dioxide (PaCO2) par-
tial pressures. Titrating these ECMO settings can involve multiple steps because, fre-
quently, the initially chosen parameters will not produce the desired result in terms of
blood gases, leading to at least one more cycle of parameter change and blood gas ana-
lysis. The whole process has to be repeated whenever the patient condition changes. As
a consequence of its lower solubility and lower volume of distribution throughout mul-
tiple compartments, PaO2 reaches equilibrium much sooner than PaCO2 [10]. There-
fore, in order to optimize the frequency of changes in ECMO settings, it would be of
utmost importance to know how long it takes for CO2 to equilibrate after ECMO sup-
port initiation or any parameter change.
Based on previous unpublished data, we have hypothesized that a 50-min period
would be enough for PaCO2 equilibrium after each change on ECMO settings. There-
fore, we conducted this experimental study to analyze the kinetics of arterial partial
pressure of carbon dioxide following the changes in ECMO parameters during apnoeic
veno-venous ECMO support.
Methods
This manuscript is part of a sequence of experiments during porcine respiratory ECMO
support, some of which were previously published elsewhere [11]. The study was ap-
proved by the Institutional Animal Research Ethics Committee from the Hospital Sírio-
Libanês in São Paulo, Brazil, and was done according to the National Institutes of
Health guidelines for the use of experimental animals. Instrumentation, surgical prepar-
ation, and lung injury were performed as previously described [11].
Instrumentation and surgical preparation
Five domestic female Agroceres pigs (80 [79,81] kg) were anesthetized with thionembu-
tal (10 mg.kg−1, thiopental, Abbott, Brazil) and pancuronium bromide (0.1 mg.kg−1,
Pavulon, AKZO Nobel, Brazil) and connected to a mechanical ventilator (Evita XL
Dräger, Dräger, Lübeck, Germany) with the following parameters: tidal volume 8 mL/
kg, end-expiratory pressure 5 cmH2O, FiO2 initially set at 100 % and subsequently ad-
justed to maintain arterial saturation between 94 and 96 %, and respiratory rate ti-
trated to maintain PaCO2 between 35 and 45 mmHg or an end-tidal CO2 (NICO,
Dixtal Biomedica Ind. Com, São Paulo, Brazil) between 30 and 40 mmHg. The elec-
trocardiogram, heart rate, oxygen saturation, and systemic pressures of the animals
were monitored with a multiparametric monitor (Infinity Delta XL, Dräger, Lübeck,
Germany). Central venous pressure (CVP), mean pulmonary artery pressure (PAPm),
pulmonary artery occluded pressure (PAOP), and cardiac output (CO) were measured
with the use of a pulmonary artery catheter. Anesthesia was maintained with midazolam
(1–5 mg.kg−1.h−1) and fentanyl (5–10 mcg.kg−1.h−1), and muscular relaxation was main-
tained with pancuronium bromide (0.2 mg.kg−1.h−1).
A 25-cm ECMO arterial cannula (Edwards Lifesciences, Irvine, CA, USA) was intro-
duced into the right external jugular vein. A 55-cm ECMO drainage cannula (Edwards
Lifesciences, Irvine, CA, USA) was positioned close to the right atrium via the right
femoral vein with the aid of transhepatic ultrasonographic visualization. Only the
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guidewires were inserted until the first baseline measurements, after the stabilization
period (Fig. 1). Heparin infusion was then started at 1000 IU/h. After the first baseline,
guidewires were replaced by the ECMO cannulas. Cannula diameter was chosen in ac-
cordance with vein diameter as measured with the aid of ultrasonography. Four animals
had a 20-Fr and one had a 21-Fr drainage cannula. Three animals had a 21-Fr and two
had a 20-Fr return cannula. A central venous catheter and an arterial line were placed
in the left femoral vein and artery, respectively.
Stabilization and support of the animals
After surgical preparation, we allowed the animals to stabilize for 1 h. A continuous in-
fusion of 3 mL.kg−1.h−1 of lactated Ringer’s solution was infused throughout the experi-
ment. Fluid challenges and vasopressors were used to maintain the mean arterial
pressure between 65 and 80 mmHg.
ECMO priming, starting, and maintenance
The ECMO system (Permanent Life Support (PLS) System, Jostra–Quadrox D, Maquet
Cardiopulmonary, Hirrlingen, Germany) was primed with a 37 °C normal saline solu-
tion and connected to a centrifugal pump (Rotaflow, Jostra, Maquet Cardiopulmonary,
Hirrlingen, Germany). Heparin infusion was titrated to keep the activated coagulation
time 1.5–2.5 times its baseline value. The absence of significant re-circulation was con-
firmed by an oxygen saturation of less than 70 % collected from the pre-membrane
port [10, 12] 10 min after the beginning of each new sweep gas flow.
Varying ECMO blood flow and sweep gas flow
The animal was kept in apnoea with 10 cmH2O of PEEP and a FiO2 = 1.0 using a con-
centric coil-resistor PEEP valve (Vital Signs Inc., Totowa, NJ, USA) with a humidified
oxygen continuous flow at 10.0 L/min. ECMO blood flow was initially set at 5.0 L/min,
and the sweep flow was set at 5.0 L/min. After 10 min, clinical and laboratorial data
were collected, and blood flow was reduced to 1500 mL/min, with an initial sweep gas
flow = 3.0 L/min. An arterial blood sample was collected every 10 min for up to
Sweep f low  = 5 L/min
Blood f low = 5000 mL/min
10 minutes
Sweep flow  = 3.0 L/min
Blood f low = 1500 mL/min
10 minutes 5 minutes 5 minutes10 minutes 5 minutes10 minutes
Sweep flow  = 1.5 L/min
Blood f low = 1500 mL/min
Sweep flow  = 10.0 L/min
Blood f low = 1500 mL/min
* * * * * * * * * * * * * * * * * * * * * *
* Data collection:
Blood gases and Hemodynamic variables
Sweep flow  = 2.0 L/min
Blood f low = 3500 mL/min
10 minutes 5 minutes 5 minutes10 minutes 5 minutes10 minutes
Sweep flow  = 3.5 L/min
Blood f low = 3500 mL/min
Sweep flow  = 7.0 L/min
Blood f low = 3500 mL/min
* * * * * * * * * * * * * * * * * * * * * *
Phase 1
Blood flow = 1500 mL/min
5 minutes10 minutes
Sweep flow  = 12.0 L/min
Blood f low = 3500 mL/min
* * * * * * *
Phase 2
Blood flow = 3500 mL/min
Fig. 1 Timeline of the whole study. Blood gases and hemodynamic variables were collected after each step
of an ECMO blood and sweep gas flow combination
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30 min; afterwards, an arterial blood sample was collected every 5 min until the new
ECMO adjustment was in place for 50 min. Carbon dioxide equilibrium was defined as
two blood gas analysis with a PaCO2 variation less than 3 %. Hemodynamic data were
also collected along with blood samples. After this step, the blood flow was kept at
1500 mL/min, and the sweep gas flow was set at 1.5 L/min and subsequently at 10.0 L/
min in 50-min intervals. Blood flow was then elevated to 3500 mL/min, and a sequence
of sweep gas flows of 2.0, 3.5, 7.0, and 12.0 L/min for 50 min each was applied (see
Fig. 1). Two different blood flows were chosen in order to evaluate the impact of blood
flow in PaCO2 equilibrium. For each ECMO blood flow, sweep gas flow sequence was
chosen arbitrarily. However, for a blood flow of 1.5 L/min, we chose an alternating se-
quence of 3.0, 1.5, and 10 L/min in order to minimize a possible carbon dioxide carry-
over phenomenon.
Time to equilibrium–time constant (tau) determination
To calculate the time constant for each sweep gas and blood flow combination, data
corresponding to the PaCO2 value along the time were fitted into the following equa-
tion [13]:
Partial pressure of CO2 ¼ a þ b  1−e−t=tau
 
where t is the time in minutes, e corresponds to Euler’s number, tau is the time con-
stant obtained for each flow combination, and a and b correspond to constants used in
the model.
Calculations
Calculations were done using standard formulas:
 Blood oxygen content CbO2 [mL O2/100 mL of blood] = 1.36 × Hb × SatbO2 +
0.0031 × PbO2
 O2 transfer [mL/min] = (1.36 × Hb × (After - pre-membrane SatO2) + 0.0031 × (After
- pre-membrane PO2)) × ECMO blood flow
 CO2 transfer [mL/min] = (CO2 partial pressure of the exhalation port of the
membrane/barometric pressure) × sweep flow in mL/min
 Blood CO2 content [mL/min] [14] = (1 − ((0.0289 × Hb)/(3.352 − 0.456 × (SatbO2/
100) × (8.142 − pHb)))) × 2.226 × 0.0307 + (0.00057 × (37 − temperature))
+ (0.00002 × (37 − temperature)2) × PbCO2 × (1 + 10
(pHb− 6.086) + (0.042 × (7.4 − pHb))
+ ((38− temperature) × 0.00472 + (0.00139 × (7.4 − pHb))))
 Oxygen delivery DO2 [mL O2/min] = cardiac output × CaO2 × 10
 Oxygen consumption VO2 [mL O2/min] = C(a − v)O2 × cardiac output × 10
 Standard base excess [SBE - mEq/L] = 0.9287 × (HCO3− − 24.4 + 14.83 × (pH − 7.4))
Statistical analysis
Normality was assessed by the Shapiro-Wilk test. Variables are shown as mean ± stand-
ard deviation if normally distributed and median and the 25th and 75th percentiles if
otherwise. Percent variations of PaCO2 at the end of the 50-min observations in each
sweep gas flow were normally distributed and compared with the paired t test. The R
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free source statistical package and comprehensive-R archive network (CRAN)-specific
libraries were used to build the graphics and analyze the data [15].
Results
During the entire experiment, arterial oxygen saturation (SatO2), pH, and standard base
excess varied across the combinations of sweep gas and blood flow; however, arterial
O2 and CO2 contents did not vary significantly. There were slight variations in
hemoglobin and electrolytes. Table 1 shows all variables measured at the end of each
50-min period of observation
Variations of PaCO2 over time with an ECMO blood flow of 1500 mL/min are shown
in Fig. 2. As expected, PaCO2 increased with the reduction of sweep gas flow from 3 to
1.5 L/min; however, an elevation of sweep gas flow from 1.5 to 10 L/min was associated
with a slight fall of PaCO2 to levels similar to those observed with 3 L/min (the PaCO2
with sweep = 3.0 L/min was 66 [55,78] mmHg, and the PaCO2 with sweep = 10.0 L/min
was 61 [48,92] mmHg, P = 0.814). In all sweep gas flows tested, the PaCO2 variation
was not statistically different at the end of 50 min; Furthermore, a percent mean differ-
ence of PaCO2 between 45 and 50 min was 2 ± 3 % (P = 0.124, paired t test), −1 ± 3 %
(P = 0.168, paired t test), and 4 ± 7 % (P = 0.338, paired t test) with the sweep gas flow
set at 3.0, 1.5, and 10.0 L/min, respectively. However, after fitting the model of PaCO2
equilibrium, we observed that with a blood flow of 1500 mL/min, the time for ascend-
ant PaCO2 stabilization phase had a time constant as high as 30 min, therefore an ex-
pected time to equilibrium of around 90 min. It is interesting to note that, differently
from expected, after reducing the sweep gas flow from 3.0 to 1.5 L/min, the time con-
stant fell from 33 ± 3 to 17 ± 4 min.
In Fig. 3, the kinetics of PaCO2 with an ECMO blood flow of 3500 mL/min is shown.
Unlike the previous condition, the increase of sweep gas flow up to 12 L/min was asso-
ciated with a progressive reduction in the PaCO2. The percent mean difference of the
PaCO2 between 45 and 50 min was 0 ± 2 % (P = 0.393, paired t test), 1 ± 1 % (P = 0.098,
paired t test), −2 ± 5 % (P = 0.357, paired t test), and 2 ± 0.4 % (P = 0.100, paired t test)
with the sweep gas flow set at 2.0, 3.5, 7.0, and 12.0 L/min, respectively.
Both ECMO blood flow and sweep gas flow affected the time to equilibrium of
PaCO2 (Fig. 4). Within the studied range of sweep gas flow and blood flow, the time
constant values varied from 6 to 33 min.
Discussion
In all conditions tested, carbon dioxide had a long time to equilibrium after changes in
ECMO settings. With an ECMO blood flow of 1500 mL/min, increases in sweep gas
flow beyond 3.0 L/min did not significantly affect PaCO2. With an ECMO blood flow
of 3500 mL/min, all increments of sweep gas flow up to 12 L/min resulted in additional
reductions of PaCO2. CO2 equilibrium was faster with higher blood and sweep gas
flows.
Unlike oxygen, which has a fast time to equilibrium and can be monitored by pulse
oximetry at the bedside [16], CO2 requires serial arterial blood gases measurements.
Differently from our initial expectative, we found long time constants for CO2 equilib-
rium with a blood flow of 1500 mL/min, suggesting that late (>50 min) assessments of
arterial blood gases are usually necessary to capture the full impact of new ECMO
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Table 1 Physiological variables after 50 min of sweep or blood flow modifications
















pH 7.21 [7.17,7.32] 7.03 [7.01,7.16] 7.26 [7.19,7.38] 7.08 [7.04,7.22] 7.16 [7.14,7.29] 7.31 [7.27,7.40] 7.43 [7.37,7.49] <0.001
SBE (mmol/L) 0.9 [0.0,1.4] −5.2 [−9.1,−1.2] 0.3 [−2.2,2.5] −0.3 [−1.7,0.4] 1.2 [−1.2,2.0] 4.3 [2.9,4.9] 4.8 [4.7,6.3] <0.001
SatO2 (%) 87 [81,98] 85 [75,96] 97 [80,99] 99 [91,100] 99 [91,100] 99 [96,99] 99 [98,100] 0.003
CaO2 (mL O2/100 mL of blood) 17 [14,17] 16 [13,18] 17 [14,18] 15 [14,18] 17 [15,18] 15 [15,19] 15 [14,18] 0.764
CaCO2 (mL CO2/100 mL of blood) 58 [57,64] 65 [54,66] 64 [58,66] 67 [63,74] 64 [61,64] 65 [63,65] 63 [63,69] 0.179
Lactate (mmol/L) 1.6 [1.3,2.2] 2.7 [1.7,3.6] 1.9 [1.7,4.3] 2.6 [1.1,3.4] 1.6 [1.6,3.2] 1.0 [1.0,1.8] 1.7 [0.8,2.1] 0.031
Hemoglobin (g/dL) 13 [12,14] 14 [13,14] 13 [12,13] 12 [11,13] 12 [12,13] 12 [11,13] 11 [10,13] 0.003
Chloride (mmol/L) 104 [103,104] 103 [103,104] 103 [103,104] 103 [103,104] 103 [103,104] 103 [102,105] 103 [103,104] 0.880
Sodium (mmol/L) 140 [138,143] 140 [139,142] 140 [137,141] 141 [138,141] 139 [138,142] 137 [137,139] 139 [136,139] 0.007
Calcium (mmol/L) 1.4 [1.4,1.4] 1.4 [1.3,1.4] 1.3 [1.3,1.3] 1.4 [1.3,1.4] 1.3 [1.3,1.4] 1.3 [1.3,1.4] 1.3 [1.3,1.3] 0.007
Glucose (mg/dL) 112 [103,131] 129 [116,214] 135 [115,158] 137 [124,138] 116 [112,127] 126 [121,128] 119 [118,121] 0.007
Pulmonary shunt (%) 47 [26,54] 60 [33,67] 45 [29,66] 67 [55,72] 54 [47,55] 56 [31,59] 50 [44,56] 0.115
Temperature (°C) 37.2 [36.8,38.5] 37.5 [36.6,38.4] 37.5 [36.4,38.2] 38.0 [37.0,38.1] 37.7 [36.9,38.2] 37.5 [37.0,38.2] 37.5 [37.0,38.2] 0.534
O2 transfer (mL/min) 116 [108,134] 115 [103,128] 133 [98,190] 246 [211,246] 201 [197,222] 206 [200,217] 207 [181,237] <0.001
CO2 transfer (mL/min) 209 [204,283] 185 [178,204] 319 [275,377] 255 [223,275] 259 [238,320] 365 [294,386] 383 [296,400] <0.001
Rotations (RPM) 2075 [1930,2175] 2075 [1980,2175] 2075 [1980,2175] 3485 [3380,3780] 3485 [3380,3780] 3485 [3380,3725] 3485 [3380,3725] <0.001
CO (L/min) 6.5 [6.4,6.9] 6.3 [4.0,6.7] 7.7 [3.6,9.4] 7.3 [4.3,9.3] 9.0 [4.4,9.1] 7.6 [4.8,8.2] 6.3 [4.8,7.9] 0.834
Heart rate (bpm) 134 [124,145] 133 [95,137] 135 [123,147] 128 [124,149] 137 [131,160] 121 [121,153] 128 [123,161] 0.867














Table 1 Physiological variables after 50 min of sweep or blood flow modifications (Continued)
PAPm (mmHg) 54 [41,59] 46 [42,47] 36 [32,46] 47 [34,48] 40 [31,47] 42 [35,45] 39 [33,44] 0.248
CVP (mmHg) 6 [5,13] 6 [4,16] 5 [4,13] 5 [3,15] 5 [4,14] 5 [4,11] 5 [4,11] 0.299
PAOP (mmHg) 11 [10,12] 8 [8,11] 8 [7,11] 7 [5,9] 8 [7,8] 8 [6,16] 8 [7,17] 0.715
Post hoc analyses were not done due to the high spectrum of comparisons (varying through the blood flow and sweep gas flows domains)
SBE standard base excess, CaO2 arterial content of oxygen, CaCO2 arterial content of CO2, CO cardiac output, ABPm mean arterial blood pressure, PAPm mean pulmonary arterial blood pressure, CVP central venous
pressure, PAOP pulmonary artery occlusion pressure














settings in low ECMO blood flow states. Furthermore, this finding is also explained by
the large volume of distribution of CO2 [17], also stored as bicarbonate, bound to
hemoglobin, and dissolved in the peripheral tissues [14, 18, 19]. The plasma dissolved
fraction (PaCO2) actually accounts for less than 5 % of the total body storage of CO2.
Therefore, small variations in PaCO2 represent large total CO2 variations [20]. Because
the changes in CO2 elimination are small in relation to its volume of distribution, the
time to equilibrium is expected to be long. Moreover, after the elevation of effective
ventilation, the reduction of the PaCO2 will depend mainly of the effective ventilation
and volume of CO2 distribution; and after the reduction of effective ventilation, the ele-
vation of PaCO2 will depend of the volume of distribution and of the CO2 production.
The last depends on other variables such as temperature, sedation, inflammatory status,
etc. Additionally, the interchange among the different molecular forms of CO2 depends
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Sweep flow = 10 L/min
Fig. 2 Observation of CO2 partial pressure during the 50-min period in each sweep gas flow step with an
ECMO blood flow set at 1500 mL/min. During the baseline, the blood flow was 5000 mL/min and sweep
flow was 5.0 L/min. With a fixed ECMO blood flow, lower sweep flow gas is associated with a progressive
increase in PaCO2 values. However, a high sweep gas flow may have limited effect in lowering PaCO2 due
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Sweep flow = 12 L/min
Fig. 3 Observation of CO2 partial pressure during the 50-min period in each sweep gas flow step with an
ECMO blood flow set at 3500 mL/min. During baseline, the blood flow was 1500 mL/min and sweep flow
was 10 L/min. With a fixed ECMO blood flow of 3500 mL/min, increases in sweep gas flow are associated
with a progressive decrease in PaCO2 values
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others [19, 21]. Thus, the time to PaCO2 equilibrium is a complex function derived
from the combination of many variables. In this study, a 50-min period was sufficient
to achieve the PaCO2 equilibrium in all sweep gas flow tested only with a blood flow of
3500 mL/min, otherwise in using 1500 mL/minute of blood flow, it may take as long as
90 min to reach the equilibrium.
We kept the animals apnoeic to restrict the elimination of CO2 to the ECMO system.
With the subjects ventilating, even with a constant minute alveolar volume, changes in
alveolar elimination of CO2 are important, because alveolar elimination depends on
both alveolar CO2 concentration and alveolar minute ventilation [11]. We reasoned
that the apnoeic model would better reflect the isolated effects of changes in ECMO
settings. In Table 1, it is possible to note that CO2 transfer and production varied im-
portantly between study steps and, more importantly, with an ECMO blood flow of
1500 mL/min. We attribute this finding mainly to the absence of CO2 stabilization
throughout the phase 1 study period, instead of marked change on CO2 production be-
tween steps. Moreover, a variation on cardiac output and unstable animal conditions
may have contributed to this finding.
At low ECMO blood flow (1500 mL/min), we found that CO2 elimination had a ceil-
ing effect at sweep gas flow of 3.0 L/min with higher gas flows exerting no significant
impact on PaCO2. This finding suggests that post-membrane CO2 was already very low
with the sweep gas flow of 3.0 L/min, and that CO2 transfer was thus perfusion limited.
This implies that, due to its high diffusibility, a very low CO2 partial pressure (its dis-
solved fraction) can be reached early during the passage of blood through the ECMO
membrane, limiting CO2 elimination independently of the sweep gas flow. This finding
is of great interest in situations in which ECMO is used mainly for hypercapnia or in
low flow devices, such as ECCO2R removal technologies.
Initial blood flow = 5000 mL/min
Initial sweep flow = 5 L/min
Time to equilibrium = 10 min
Fig. 4 Time constant calculation for each sweep and blood flow combinations. The initial blood and sweep
flow of each combination was the last combination of the precedent graphic, except for the first graph.
Tau denotes time constant, and its calculation is explained in the text
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Our study has several limitations: (1) The low number of animals could lead to type-
II errors, attenuating the validity of our results. However, such a limitation would not
affect our positive findings. (2) We did not study animals with multi-organ failure syn-
drome, a condition likely closer to a clinical scenario. However, many positive associa-
tions will be intuitively the same. (3) As presented in Table 1, we observed a progressive
decrease in hemoglobin concentration throughout the experiment. Considering that
hemoglobin acts as a CO2 reservoir, this may have influenced the results. (4) We did the
analysis with a static 50-min period to gas equilibrium. With low ECMO blood flows, it
was not enough for PaCO2 to reach the equilibrium and, therefore, definitive time to equi-
librium for such situation remains unknown. Moreover, it is possible that late inter-
compartment distributions may occur, affecting our results.
Conclusions
In conclusion, our results suggest that 50 min was enough to reach the equilibrium of
PaCO2 after ECMO initiation or after changes in blood and sweep gas flow with an
ECMO blood flow of 3500 mL/min. Longer periods are necessary to reach the equilib-
rium with an ECMO blood flow of 1500 mL/min. This may help bedside decisions and
facilitate daily management of patients during ECMO support.
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